Claire Vandiedonck

Dr. Claire Vandiedonck

Inserm UMR-S-958 "Genetics of diabetes", University Paris Diderot - Paris 7, School of Medicine, Site Villemin, 10 avenue de Verdun, 75010 Paris, France
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2007 in Nature
Verified
Journal Article
Closed access
MGMatthieu Giraud
Matthieu Giraud
RTRichard Taubert
Richard Taubert
CVClaire Vandiedonck
Claire Vandiedonck
XKXiayi Ke
Xiayi Ke
MLMatthieu Lévi-Strauss
Matthieu Lévi-Strauss
HGHenri-Jean Garchon
Henri-Jean Garchon

25 May 2009 in Briefings in Functional Genomics and Proteomics
Verified
Journal Article
Open access
PDF file
CVClaire Vandiedonck
Claire Vandiedonck
JKJulian C. Knight
Julian C. Knight
Since its discovery more than 50 years ago, the human Major Histocompatibility Complex (MHC) on chromosome 6p21.3 has been at the forefront of human genetic research. Here, we review from a historical perspective the major advances in our understanding of the nature and consequences of genetic variation which have involved the MHC, as well as highlighting likely future directions. As a consequence of its particular genomic structure, its remarkable polymorphism and its early implication in numerous diseases, the MHC has been considered as a model region for genomics, being the first substantial region to be sequenced and establishing fundamental concepts of linkage disequilibrium, haplotypic structure and meiotic recombination. Recently, the MHC became the first genomic region to be entirely re-sequenced for common haplotypes, while studies mapping gene expression phenotypes across the genome have strongly implicated variation in the MHC. This review shows how the MHC continues to provide new insights and remains in the vanguard of contemporary research in human genomics.

25 January 2006 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
CVClaire Vandiedonck
Claire Vandiedonck
CCClaire Capdevielle
Claire Capdevielle
MGMatthieu Giraud
Matthieu Giraud
SKSophie Krumeich
Sophie Krumeich
JJJean‐Philippe Jais
Jean‐Philippe Jais
HGHenri‐Jean Garchon
Henri‐Jean Garchon

15 October 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CVClaire Vandiedonck
Claire Vandiedonck
GBGeneviève Beaurain
Geneviève Beaurain
MGMatthieu Giraud
Matthieu Giraud
CHCatherine Hue-Beauvais
Catherine Hue-Beauvais
BEBruno Eymard
Bruno Eymard
HGHenri-Jean Garchon
Henri-Jean Garchon
The 8.1 haplotype of the HLA complex has been reproducibly associated with several autoimmune diseases and traits, notably with thymus hyperplasia in patients with acquired generalized myasthenia gravis, an autoantibody-mediated disease directed at the muscle acetylcholine receptor. However, the strong linkage disequilibrium across this haplotype has prevented the identification of the causative locus, termed MYAS1. Here, we localized MYAS1 to a 1.2-Mb genome segment by reconstructing haplotypes and assessing their transmission in 73 simplex families. This segment encompasses the class III and proximal class I regions, between the BAT3 and C3-2-11 markers, therefore unambiguously excluding the class II loci. In addition, a case-control study revealed a very strong association with a core haplotype in this same region following an additive model ( P = 7 × 10 -11 , odds ratio 6.5 for one copy and 42 for two copies of the core haplotype). Finally, we showed that this region is associated with a marked increase in serum titers of anti-acetylcholine receptor autoantibodies ( P = 8 × 10 -6 ). Remarkably, this effect was suppressed by a second locus in cis on the 8.1 haplotype and located toward the class II region. Altogether, these data demonstrate the highly significant but complex effects of the 8.1 haplotype on the phenotype of myasthenia gravis patients and might shed light on its role in other autoimmune diseases.

28 June 2008 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MGMatthieu Giraud
Matthieu Giraud
CVClaire Vandiedonck
Claire Vandiedonck
HGHenri‐Jean Garchon
Henri‐Jean Garchon

31 May 2011 in Genome Research
Verified
Journal Article
Closed access
PDF file
CVClaire Vandiedonck
Claire Vandiedonck
MTMartin S. Taylor
Martin S. Taylor
HLHelen E. Lockstone
Helen E. Lockstone
KPKatharine Plant
Katharine Plant
JTJennifer M. Taylor
Jennifer M. Taylor
JKJulian C. Knight
Julian C. Knight
The human major histocompatibility complex (MHC) on chromosome 6p21 is a paradigm for genomics, showing remarkable polymorphism and striking association with immune and non-immune diseases. The complex genomic landscape of the MHC, notably strong linkage disequilibrium, has made resolving causal variants very challenging. A promising approach is to investigate gene expression levels considered as tractable intermediate phenotypes in mapping complex diseases. However, how transcription varies across the MHC, notably relative to specific haplotypes, remains unknown. Here, using an original hybrid tiling and splice junction microarray that includes alternate allele probes, we draw the first high-resolution strand-specific transcription map for three common MHC haplotypes (HLA-A1-B8-Cw7-DR3, HLA-A3-B7-Cw7-DR15, and HLA-A26-B18-Cw5-DR3-DQ2) strongly associated with autoimmune diseases including type 1 diabetes, systemic lupus erythematosus, and multiple sclerosis. We find that haplotype-specific differences in gene expression are common across the MHC, affecting 96 genes (46.4%), most significantly the zing finger protein gene ZFP57. Differentially expressed probes are correlated with polymorphisms between haplotypes, consistent with cis effects that we directly demonstrate for ZFP57 in a cohort of healthy volunteers (P = 1.2 × 10−14). We establish that alternative splicing is significantly more frequent in the MHC than genome-wide (72.5% vs. 62.1% of genes, P ≤ 1 × 10−4) and shows marked haplotypic differences. We also unmask novel and abundant intergenic transcription involving 31% of transcribed blocks identified. Our study reveals that the renowned MHC polymorphism also manifests as transcript diversity, and our novel haplotype-based approach marks a new step toward identification of regulatory variants involved in the control of MHC-associated phenotypes and diseases.